Veterinary Regenerative Medicine Market to Hit $870M by 2032
The global animal regenerative therapies market is projected to reach $870 million by 2032, fueled by rapid advancements in veterinary biotechnology and a surge in pet owner spending. This growth reflects a broader shift toward adopting human-grade medical innovations, such as stem cell and PRP treatments, for companion animals and livestock.